Limits...
Antiproliferative activity of violaxanthin isolated from bioguided fractionation of Dunaliella tertiolecta extracts.

Pasquet V, Morisset P, Ihammouine S, Chepied A, Aumailley L, Berard JB, Serive B, Kaas R, Lanneluc I, Thiery V, Lafferriere M, Piot JM, Patrice T, Cadoret JP, Picot L - Mar Drugs (2011)

Bottom Line: High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract.Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 μg·mL⁻¹ (0.17 μM).Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 μg·mL⁻¹ (13.3 μM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 μg·mL⁻¹ (66.7 μM).

View Article: PubMed Central - PubMed

Affiliation: UMR CNRS 6250 LIENSs, University of La Rochelle, F-17042 La Rochelle, France.

ABSTRACT
Dunaliella tertiolecta (DT) was chemically investigated to isolate molecules inhibiting cancer cell proliferation and inducing apoptosis in vitro. The potency to inhibit cell growth was used for the bio-guided fractionation and isolation of active compounds using chromatographic techniques. The DT dichloromethane extract exhibited a strong anti-proliferative activity on MCF-7 and LNCaP cells, and was further fractionated and sub-fractionated by RP-HPLC. High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract. Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 μg·mL⁻¹ (0.17 μM). Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 μg·mL⁻¹ (13.3 μM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 μg·mL⁻¹ (66.7 μM). Taken together, our results demonstrate the strong antiproliferative activity of violaxanthin on one human mammary cancer cell line, and suggest that studying the pharmacology of violaxanthin and pharmacomodulated derivatives on cancer cells may allow potent antiproliferative drugs to be obtained.

Show MeSH

Related in: MedlinePlus

Growth kinetics of MCF-7 continuously treated with the DT DCM sub-fraction F1.4.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC3111184&req=5

f3-marinedrugs-09-00819: Growth kinetics of MCF-7 continuously treated with the DT DCM sub-fraction F1.4.

Mentions: The antiproliferative activity of the most active sub-fraction, F1.4, was assessed on MCF-7 continuously exposed for 72 h to increasing concentrations in the cell culture medium. F1.4 inhibited MCF-7 growth at a concentration as low as 0.1 μg·mL−1 and in a dose-dependent manner from 0.1 to 40 μg·mL−1 (Figure 3).


Antiproliferative activity of violaxanthin isolated from bioguided fractionation of Dunaliella tertiolecta extracts.

Pasquet V, Morisset P, Ihammouine S, Chepied A, Aumailley L, Berard JB, Serive B, Kaas R, Lanneluc I, Thiery V, Lafferriere M, Piot JM, Patrice T, Cadoret JP, Picot L - Mar Drugs (2011)

Growth kinetics of MCF-7 continuously treated with the DT DCM sub-fraction F1.4.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC3111184&req=5

f3-marinedrugs-09-00819: Growth kinetics of MCF-7 continuously treated with the DT DCM sub-fraction F1.4.
Mentions: The antiproliferative activity of the most active sub-fraction, F1.4, was assessed on MCF-7 continuously exposed for 72 h to increasing concentrations in the cell culture medium. F1.4 inhibited MCF-7 growth at a concentration as low as 0.1 μg·mL−1 and in a dose-dependent manner from 0.1 to 40 μg·mL−1 (Figure 3).

Bottom Line: High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract.Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 μg·mL⁻¹ (0.17 μM).Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 μg·mL⁻¹ (13.3 μM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 μg·mL⁻¹ (66.7 μM).

View Article: PubMed Central - PubMed

Affiliation: UMR CNRS 6250 LIENSs, University of La Rochelle, F-17042 La Rochelle, France.

ABSTRACT
Dunaliella tertiolecta (DT) was chemically investigated to isolate molecules inhibiting cancer cell proliferation and inducing apoptosis in vitro. The potency to inhibit cell growth was used for the bio-guided fractionation and isolation of active compounds using chromatographic techniques. The DT dichloromethane extract exhibited a strong anti-proliferative activity on MCF-7 and LNCaP cells, and was further fractionated and sub-fractionated by RP-HPLC. High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract. Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 μg·mL⁻¹ (0.17 μM). Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 μg·mL⁻¹ (13.3 μM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 μg·mL⁻¹ (66.7 μM). Taken together, our results demonstrate the strong antiproliferative activity of violaxanthin on one human mammary cancer cell line, and suggest that studying the pharmacology of violaxanthin and pharmacomodulated derivatives on cancer cells may allow potent antiproliferative drugs to be obtained.

Show MeSH
Related in: MedlinePlus